No Data
No Data
Virax Biolabs Achieves Shareholder Approvals at Adjourned Annual Meeting
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Virax Biolabs Announces 2025 Strategic Priorities, Highlighting Clinical Validation For Viraximmune And Global Expansion of ImmuneSelect
Virax Biolabs' CEO James Foster Issues Letter to Shareholders
Virax Biolabs Announces Agreement With Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland
Express News | World Health Organization Says Mpox Continues To Constitute A Public Health Emergency Of International Concern
No Data